1.
Job Openings: Onyx Pharmaceuticals
Job Title: Financial Systems Analyst. Description: ... There will be collaboration planning opportunities with various process stakeholders including FP&A, ...
2.
Onyx Pharmaceuticals: Home
Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Show stock quote for ONXX
3.
FDA Approves Nexavar® for Treatment of Patients with Advanced ...
Dec 20, 2005 ... FDA Approves Nexavar® for Treatment of Patients with Advanced Kidney Cancer. First FDA Approved Treatment in this Indication in More Than a ...
4.
Nexavar First FDA-Approved Drug Therapy for Liver Cancer: Onyx ...
Nov 19, 2007 ... Nexavar First FDA-Approved Drug Therapy for Liver Cancer ... and Drug Administration (FDA) has approved a supplemental New Drug Application ...
5.
Onyx Pharmaceuticals To Present At The Barclays Capital Global ...
Mar 3, 2009 ... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Barclays Capital Global Healthcare Conference on ...
6.
Glossary: Onyx Pharmaceuticals
progression. Worsening of a cancer. The opposite of regression. ... The opposite of progression. Regression can be partial or it can be complete (meaning ...
7.
Nexavar First FDA-Approved Drug Therapy for Liver Cancer: Onyx ...
Nov 19, 2007 ... Nexavar, an oral anticancer drug, is the first approved systemic ... patient support program - Resources for Expert Assistance and Care ...
8.
Nexavar (sorafenib) tablets
File Format: PDF/Adobe Acrobat NEXAVAR (1.866.639.2827). Nexavar's approval in the U.S. followed a report at the annual meeting of the American Society of Clinical Oncology ...
9.
Bayer and Onyx Announce Nexavar Data Presentations at 44th ...
o Barbara Gitlitz, MD, associate professor of clinical, director, Lung, Head and Neck Program, USC/Norris Comprehensive Cancer Center, Los Angeles, CA ...
10.
Cell Cycle Kinase Inhibitor: Onyx Pharmaceuticals
Cell Cycle Kinase Inhibitor. In collaboration with Warner-Lambert Company, a subsidiary of Pfizer Inc, we identified a number of lead compounds that ...
